284 related articles for article (PubMed ID: 18211009)
1. High confidence predictions of drug-drug interactions: predicting affinities for cytochrome P450 2C9 with multiple computational methods.
Hudelson MG; Ketkar NS; Holder LB; Carlson TJ; Peng CC; Waldher BJ; Jones JP
J Med Chem; 2008 Feb; 51(3):648-54. PubMed ID: 18211009
[TBL] [Abstract][Full Text] [Related]
2. Ligand-based models for the isoform specificity of cytochrome P450 3A4, 2D6, and 2C9 substrates.
Terfloth L; Bienfait B; Gasteiger J
J Chem Inf Model; 2007; 47(4):1688-701. PubMed ID: 17608404
[TBL] [Abstract][Full Text] [Related]
3. Predicting drug metabolism: a site of metabolism prediction tool applied to the cytochrome P450 2C9.
Zamora I; Afzelius L; Cruciani G
J Med Chem; 2003 Jun; 46(12):2313-24. PubMed ID: 12773036
[TBL] [Abstract][Full Text] [Related]
4. QSAR modeling of human serum protein binding with several modeling techniques utilizing structure-information representation.
Votano JR; Parham M; Hall LM; Hall LH; Kier LB; Oloff S; Tropsha A
J Med Chem; 2006 Nov; 49(24):7169-81. PubMed ID: 17125269
[TBL] [Abstract][Full Text] [Related]
5. Designing better drugs: predicting cytochrome P450 metabolism.
de Groot MJ
Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528
[TBL] [Abstract][Full Text] [Related]
6. Combinatorial QSAR modeling of P-glycoprotein substrates.
de Cerqueira Lima P; Golbraikh A; Oloff S; Xiao Y; Tropsha A
J Chem Inf Model; 2006; 46(3):1245-54. PubMed ID: 16711744
[TBL] [Abstract][Full Text] [Related]
7. Line-walking method for predicting the inhibition of P450 drug metabolism.
Hudelson MG; Jones JP
J Med Chem; 2006 Jul; 49(14):4367-73. PubMed ID: 16821796
[TBL] [Abstract][Full Text] [Related]
8. Predicting ADME properties and side effects: the BioPrint approach.
Krejsa CM; Horvath D; Rogalski SL; Penzotti JE; Mao B; Barbosa F; Migeon JC
Curr Opin Drug Discov Devel; 2003 Jul; 6(4):470-80. PubMed ID: 12951810
[TBL] [Abstract][Full Text] [Related]
9. Predictive toxicology: benchmarking molecular descriptors and statistical methods.
Feng J; Lurati L; Ouyang H; Robinson T; Wang Y; Yuan S; Young SS
J Chem Inf Comput Sci; 2003; 43(5):1463-70. PubMed ID: 14502479
[TBL] [Abstract][Full Text] [Related]
10. Molecule kernels: a descriptor- and alignment-free quantitative structure-activity relationship approach.
Mohr JA; Jain BJ; Obermayer K
J Chem Inf Model; 2008 Sep; 48(9):1868-81. PubMed ID: 18767832
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of in silico models for estimating drug preformulation risk in PEG400/water and Tween80/water systems.
Crivori P; Morelli A; Pezzetta D; Rocchetti M; Poggesi I
Eur J Pharm Sci; 2007 Nov; 32(3):169-81. PubMed ID: 17714921
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of k-nearest-neighbor QSPR models of metabolic stability of drug candidates.
Shen M; Xiao Y; Golbraikh A; Gombar VK; Tropsha A
J Med Chem; 2003 Jul; 46(14):3013-20. PubMed ID: 12825940
[TBL] [Abstract][Full Text] [Related]
13. In silico predictive metabolism: a structural/electronic filter method.
Harris DL
Curr Opin Drug Discov Devel; 2004 Jan; 7(1):43-8. PubMed ID: 14982147
[TBL] [Abstract][Full Text] [Related]
14. Modeling of human cytochrome p450-mediated drug metabolism using unsupervised machine learning approach.
Korolev D; Balakin KV; Nikolsky Y; Kirillov E; Ivanenkov YA; Savchuk NP; Ivashchenko AA; Nikolskaya T
J Med Chem; 2003 Aug; 46(17):3631-43. PubMed ID: 12904067
[TBL] [Abstract][Full Text] [Related]
15. Modeling and synthesis of novel tight-binding inhibitors of cytochrome P450 2C9.
Peng CC; Rushmore T; Crouch GJ; Jones JP
Bioorg Med Chem; 2008 Apr; 16(7):4064-74. PubMed ID: 18255300
[TBL] [Abstract][Full Text] [Related]
16. Quantitative structure-activity relationship modeling of juvenile hormone mimetic compounds for Culex pipiens larvae, with a discussion of descriptor-thinning methods.
Basak SC; Natarajan R; Mills D; Hawkins DM; Kraker JJ
J Chem Inf Model; 2006; 46(1):65-77. PubMed ID: 16426041
[TBL] [Abstract][Full Text] [Related]
17. In silico ADME modelling 2: computational models to predict human serum albumin binding affinity using ant colony systems.
Gunturi SB; Narayanan R; Khandelwal A
Bioorg Med Chem; 2006 Jun; 14(12):4118-29. PubMed ID: 16504519
[TBL] [Abstract][Full Text] [Related]
18. Local and global quantitative structure-activity relationship modeling and prediction for the baseline toxicity.
Yuan H; Wang Y; Cheng Y
J Chem Inf Model; 2007; 47(1):159-69. PubMed ID: 17238261
[TBL] [Abstract][Full Text] [Related]
19. Spline-fitting with a genetic algorithm: a method for developing classification structure-activity relationships.
Sutherland JJ; O'Brien LA; Weaver DF
J Chem Inf Comput Sci; 2003; 43(6):1906-15. PubMed ID: 14632439
[TBL] [Abstract][Full Text] [Related]
20. The first structure of a microsomal P450--implications for drug discovery.
Tennant M; McRee DE
Curr Opin Drug Discov Devel; 2001 Sep; 4(5):671-7. PubMed ID: 12825462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
